Events

Pune, India – September 24, 2026 -- The global nanomedicine market reached USD 207.91 billion in 2025 and is projected to hit USD 581.2 billion by 2034, expanding at a 12.1% compound annual growth rate, according to a new report from Maximize Market Research.

North America commands the largest share on pharmaceutical R&D strength

North America held the largest share of the market in 2025, driven by advanced healthcare infrastructure, deep pharmaceutical and biotechnology research pipelines, and high healthcare expenditure. The United States anchors regional growth through its established research ecosystem and rising adoption of nanotechnology-based drug delivery, diagnostics and precision medicine platforms. Canada and Mexico are contributing through expanding healthcare capabilities and research initiatives.

San Francisco – September 24, 2026 -- The U.S. Bankruptcy Court for the District of New Jersey approved HouseCanary's first-day motions, granting the property intelligence provider access to debtor-in-possession financing and clearing the way for uninterrupted operations during its Chapter 11 reorganization.

Court clears customer, employee and financing relief on first-day hearing

The approved motions cover continuation of customer programs, employee obligations and ordinary-course business operations, alongside debtor-in-possession financing to bolster liquidity. A further hearing is scheduled for October to consider additional debtor-in-possession financing for the company.

Bogotá – September 24, 2026 -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC) named Joaquín Gutiérrez Caballero as permanent Chief Executive Officer, effective September 28, 2026, following a unanimous board vote.

Board replaces interim leadership with unanimous vote

The appointment ends the interim tenure of Camilo Barco, who steps down as CEO effective September 27, 2026. All members of Ecopetrol's Board of Directors participated in the vote, which followed a selection process run by the Board's Compensation, Nomination and Culture Committee under the company's Succession Policy.

Incoming CEO brings 30 years of cross-sector experience

Gutiérrez Caballero holds a degree in Business Administration and postgraduate specializations in Telecommunications Project Management, Telecommunications Law, and Healthcare Services Management. He has more than 30 years of professional experience, according to the company.

Easton, PA – September 24, 2026 -- A structured construction management workflow is reducing cost overruns and schedule delays on market-rate residential projects, according to a new HelloNation article featuring insights from Construction Management Expert Jovana Villanueva of Easton, PA.

Pre-construction planning cuts change orders before ground is broken

The article details how early cost modeling, material availability checks, and constructability reviews of architectural drawings identify design conflicts before construction starts. This upfront analysis is presented as the primary lever developers have to reduce change orders and keep projects aligned with financial targets from day one.

St. Petersburg – September 24, 2026 -- ARK Investment Management LLC has launched the ARK Active Autocallable Income ETF (ARKY), targeting a 17.5% coupon by applying a volatility-harvesting strategy to its disruptive-innovation equity universe. The fund began trading on the Cboe BZX Exchange, marking ARK's first entry into the income-strategy category.

ARKY diversifies risk across 25 to 50 single-stock autocallable positions

Each holding in the portfolio references a single stock from ARK's high-conviction innovation universe and carries a 50% to 60% coupon barrier. A breach in one underlying asset affects only that position, while the remaining portfolio can continue generating income, according to the company.

Pune, India – September 24, 2026 -- The global multiple sclerosis treatment market reached USD 26.76 billion in 2025 and is forecast to climb to USD 44.45 billion by 2034, expanding at a 5.8% CAGR, according to a new report from Maximize Market Research.

Disease-modifying therapies and biologics drive current market expansion

Rising MS prevalence, improved diagnostic capabilities, and growing adoption of immunomodulators, immunosuppressants, interferons, oral disease-modifying therapies (DMTs), and monoclonal antibodies are fueling demand across relapsing-remitting (RRMS), primary progressive (PPMS), secondary progressive (SPMS), and clinically isolated syndrome (CIS) patient segments. High-efficacy biologics and oral treatment options are increasingly displacing older therapy classes as patients and physicians prioritize convenience and disease-progression control.

Pune, India – September 24, 2026 -- The global placenta market is set to nearly triple from USD 96.1 billion in 2025 to USD 275.18 billion by 2034, expanding at a 12.4% compound annual growth rate, according to a new analysis by Maximize Market Research.

Asia-Pacific leads global demand as Japan, South Korea and China drive placenta research

Asia-Pacific held the leading market position in 2025, backed by strong placenta research and development in Japan, South Korea and China, alongside rising production of placenta-derived products for pharmaceutical and cosmetics applications. The region's large consumer base and appetite for anti-aging and skincare solutions continue to underpin its dominant position.

Austin, Texas – September 24, 2026 -- Forge AI Deployment has committed $30 million to webAI to build and deploy private, specialized AI systems for enterprise customers, the companies announced.

Forge pairs $30 million commitment with webAI's collaborative intelligence platform

The deal combines webAI's technology with Forge's enterprise deployment and services operation. Forge will work directly with customers to build AI systems around proprietary data, workflows and operations, running on infrastructure those customers control, from individual specialized AI Personas to company-wide deployments.

Washington – September 24, 2026 -- State insurance regulators leading the National Association of Insurance Commissioners (NAIC) responded to a letter from U.S. Senator Elizabeth Warren (D-Mass.) by detailing a series of capital and oversight changes made in recent years to address insurers' shifting investment strategies, ownership structures, and risk-transfer arrangements.

Regulators impose a 45% risk-based capital charge on structured security residuals

Pune – September 24, 2026 -- The global bioinformatics market is projected to expand from $20.34 billion in 2025 to $64.60 billion by 2034, a 13.7% compound annual growth rate, according to new analysis from Maximize Market Research.

Genomic data volumes and NGS adoption fuel core demand

Rising volumes of genomic and biological data, driven by expanding next-generation sequencing (NGS) adoption, are pushing pharmaceutical and biotechnology companies toward advanced bioinformatics platforms, sequencing data analysis tools, and biological databases. Declining sequencing costs are drawing smaller research institutions into the market, while growing precision medicine applications are increasing demand for pharmacogenomics, biomarker analysis, and genomic diagnostics.

Houston – September 24, 2026 -- CenterPoint Energy has secured a $50 million federal award from the U.S. Department of Energy to fund advanced substation technology upgrades across its Greater Houston service territory, making it one of the first U.S. utilities to deploy Siemens Energy's transmission grid-stabilizing systems.

DOE selects CenterPoint under SPARK program to modernize transmission infrastructure

The funding was awarded through DOE's Speed to Power through Accelerated Reconductoring and other Key Advanced Transmission Technology Upgrades (SPARK) program, which targets modernization of existing electrical infrastructure to meet rising demand and lower electricity costs for roughly 100 million Americans nationwide. CenterPoint said the award will support technology capable of responding rapidly to shifts in electricity demand, helping stabilize service for one of the fastest-growing regions in Texas.

San Antonio – September 24, 2026 -- Sixty-three percent of in-market vehicle shoppers say they will definitely or probably use AI during their next vehicle purchase, while only 29% of dealers report actively adjusting for AI-powered search, according to Cox Automotive's Q2 2026 AI in Auto Retail Tracker. The survey, fielded in May 2026, polled 483 franchise and independent dealership decision-makers and 1,502 consumers planning a vehicle purchase within 12 months.

AI tools now rival automotive websites as a research channel

Cox Automotive found 36% of shoppers now use AI tools for vehicle research, nearly matching the 38% who rely on automotive-specific websites. Among AI users, 26% ask AI to generate questions for dealers and 24% say it makes them feel more prepared for dealership visits, while only 17% cite avoiding dealership staff as a benefit -- indicating AI use is largely preparatory rather than a replacement for dealer interaction.

Atlanta – September 24, 2026 -- Delta Air Lines (NYSE: DAL) has declared a quarterly dividend of $0.2150 per share, its Board of Directors confirmed.

Delta Sets $0.2150 Per-Share Payout for Shareholders

The dividend applies to all shareholders of record as of the close of business on October 15, 2026. Delta will distribute the payment on November 5, 2026.

Carrier Operates 5,500 Daily Flights Across Six Continents

The Atlanta-based airline runs up to 5,500 daily Delta and Delta Connection flights to more than 300 destinations, supported by a workforce of 100,000 employees. Delta carried over 200 million customers in 2025.

Delta Ranked North America's Most On-Time Airline for 2025

Cirium recognized Delta as North America's most on-time carrier last year, while J.D. Power ranked the airline No. 1 in Premium Economy Passenger Satisfaction in 2025.

Reston – September 24, 2026 -- ICF (NASDAQ: ICFI) will release its third-quarter 2026 financial results on Thursday, November 5, 2026, after market close.

ICF sets Nov. 5 webcast to discuss Q3 results with investors

The global solutions and technology provider will host a webcast at 4:30 p.m. Eastern time the same day to walk analysts and institutional investors through the quarterly financials.

Earnings figures will post to ICF's investor site ahead of the call

Full results will be available at ICF's investor relations page before the webcast begins. Analysts and institutional investors can register in advance to receive dial-in credentials and a unique PIN, while general listeners can join the live webcast without registration.

A replay of the webcast will remain accessible for one year following the live event.

Dallas – – September 24, 2026 -- AT&T's board of directors declared a quarterly dividend of $0.2775 per share on the company's common shares, payable Nov. 2, 2026, to stockholders of record as of the close of business Oct. 12, 2026.

AT&T sets preferred stock payouts alongside common dividend

The board also approved quarterly dividends on AT&T's 5.000% Perpetual Preferred Stock, Series A, and its 4.750% Perpetual Preferred Stock, Series C. The Series A dividend totals $312.50 per preferred share, equivalent to $0.3125 per depositary share. The Series C dividend is set at $296.875 per preferred share, or $0.296875 per depositary share.

All dividend classes share the same record and payment dates

Common stock, Series A and Series C preferred stock dividends will all be paid on Nov. 2, 2026, to holders of record at the close of business on Oct. 12, 2026.

Friendswood, Texas – September 24, 2026 -- More than half of atopic dermatitis (AD) patients who used targeted systemic therapies modified treatment because the drugs failed to work, according to a new study published in Dermatology and Therapy by Castle Biosciences, Inc. (Nasdaq: CSTL).

Study finds 55% of systemic therapy users switched due to lack of efficacy

The research surveyed 43 AD patients and caregivers who completed a 32-question assessment at the 2024 National Eczema Association Eczema Expo. Among respondents who had used targeted systemic therapies, 55% reported modifying treatment because of insufficient results. Inadequate skin clearance and persistent itching were cited as the most frequent reasons for switching drugs or adding topical treatments.

Vancouver, BC – September 24, 2026 -- 1911 Gold Corporation has filed a National Instrument 43-101 Technical Report confirming an Inferred Mineral Resource of 3,314,000 tonnes grading 6.68 grams per tonne gold, containing 712,000 ounces, at its 100%-owned Ogama-Rockland Gold Project in southeastern Manitoba.

Updated resource estimate follows August 11 disclosure

The Technical Report, dated September 24, 2026 with an effective date of August 6, 2026, formalizes the 2026 Mineral Resource Estimate first announced by the company on August 11, 2026. It has been filed on SEDAR+ and posted to the company's website. The report was prepared by Tim Maunula, P.Geo, of T. Maunula & Associates Consulting Inc., and Roselyn Yeboah, P.Eng, of 1911 Gold, both designated Qualified Persons under NI 43-101.

McLean, Va. – September 24, 2026 -- Iridium Communications Inc. (Nasdaq: IRDM) stockholders have formally approved the company's acquisition by Rocket Lab Corporation (Nasdaq: RKLB), clearing a critical hurdle for a deal valued at $54.00 per share on a notional basis.

Shareholders back the deal with overwhelming margin

At a special meeting, approximately 99.6% of votes cast supported the merger agreement, representing roughly 81.0% of Iridium's total outstanding common stock entitled to vote. Full voting results will be disclosed in a Form 8-K filing with the U.S. Securities and Exchange Commission.

Deal terms combine cash and stock in collared exchange

Under the agreement, Iridium stockholders will receive $27.00 in cash plus Rocket Lab shares calculated under an exchange ratio subject to a collar, for each share of Iridium common stock held at closing. The combined consideration carries a notional value of $54.00 per Iridium share.

Quanzhou, China – September 24, 2026 -- INLIF LIMITED (Nasdaq: INLF) swung to a net income of $1.01 million in the first half of fiscal year 2026, reversing a $1.98 million net loss in the same period last year, an improvement of approximately $3.0 million.

Net revenue climbed 26.01% to $12.94 million on new intelligent equipment sales

Net revenue rose to $12.94 million from $10.27 million a year earlier. The gain was driven by a $0.60 million increase in manipulator arm sales, including installation and warranty services, plus $3.36 million in new revenue from the company's intelligent equipment business, which had no revenue contribution in the prior-year period. Sales of raw materials and scraps fell $1.27 million as INLIF shifted to a more demand-driven procurement model.

Arlington, Va. – September 24, 2026 -- Info-Tech Research Group has released a new blueprint, Position Your Brand Strategically as a Cost or Value Leader, offering a three-step framework to help organizations resolve strategic ambiguity between cost efficiency and premium differentiation.

Organizations Split Between Cost and Value Models Risk Getting 'Stuck in the Middle'

The blueprint states that cost leaders depend on efficiency, standardization, and disciplined cost control to serve price-sensitive markets, while value leaders rely on innovation, customer experience, and brand strength to command premium pricing. Firms that pursue both without clear tradeoffs risk lacking a sustainable cost advantage or meaningful differentiation, according to the research.